How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry Ilana N. AckermanRichard NormanSze-Ee Soh Original Research Article Open access 15 June 2024
The Cost-Effectiveness of Primary Prevention Interventions for Skin Cancer: An Updated Systematic Review Louisa G. CollinsRyan GageDaniel Lindsay Systematic Review 11 June 2024
Cost of Carbon in the Total Cost of Healthcare Procedures: A Methodological Challenge Paul-Simon PugliesiLaurie MarrauldCatherine Lejeune Practical Application 11 June 2024
Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand Rungroj KrittayaphongUnchalee Permsuwan Original Research Article 10 June 2024
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally Sabine VoglerKatharina HabimanaStefan Fischer Review Article 05 June 2024
Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa Pim W. M. van DorstSimon van der PolAntoinette D. I. van Asselt Original Research Article Open access 25 May 2024
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit Dominic Muston Practical Application 21 May 2024
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden Chiara MalmbergMagnus VärendhErik Eklund Original Research Article 17 May 2024 Pages: 543 - 554
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening Stuart J. WrightEwan GrayKatherine Payne Original Research Article Open access 16 May 2024 Pages: 527 - 542
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis Umenthala Srikanth Reddy Systematic Review 10 May 2024 Pages: 471 - 483
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study Theodore LaetschJie ZhangLouis Garrison Original Research Article Open access 29 April 2024
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China Ningxin DingHuixuan ZhouYunfeng Shi Original Research Article 19 April 2024 Pages: 555 - 568
Health Economics in a World of Uneconomic Growth Martin HensherGerry McCartneyEleanor Ochodo Current Opinion Open access 18 April 2024 Pages: 427 - 433
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis Enxue ChangHaofei LiWeidong Huang Systematic Review 10 April 2024 Pages: 457 - 470
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment Mohsen Ghaffari DarabLidia EngelCathrine Mihalopoulos Systematic Review Open access 30 March 2024 Pages: 503 - 525
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities Muhammad Iftikhar ul HusnainMohammad HajizadehRasheda Khanam Original Research Article Open access 26 March 2024 Pages: 583 - 598
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study Matthew FranklinSebastian HindeWilliam Whittaker Current Opinion Open access 11 March 2024 Pages: 435 - 445
Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India Jyoti DixitPankaj MalhotraShankar Prinja Original Research Article 07 March 2024 Pages: 569 - 582
Cost of Low-Value Imaging Worldwide: A Systematic Review Elin KjelleIngrid Øfsti BrandsæterBjørn Morten Hofmann Systematic Review Open access 01 March 2024 Pages: 485 - 501
#SharingHEOR: Developing Modern Media for Communication and Dissemination of Health Economics and Outcomes Research Davene R. WrightMikaela BatistaTim Wrightson Practical Application 01 March 2024 Pages: 447 - 455
The Impact of Raising Alcohol Taxes on Government Tax Revenue: Insights from Five European Countries Jakob MantheyInese GobiņaJürgen Rehm Original Research Article Open access 22 February 2024 Pages: 363 - 374
Simplified Methods for Modelling Dependent Parameters in Health Economic Evaluations: A Tutorial Xuanqian XieAlexis K. SchainkAndrei Volodin Practical Application 20 February 2024 Pages: 331 - 341
Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose? Helen DakinApostolos Tsiachristas Practical Application Open access 08 February 2024 Pages: 315 - 329
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations Bethany ShinkinsA. Joy AllenBrigitta U. Monz Practical Application Open access 05 February 2024 Pages: 131 - 144
What Interventions are Cost Effective in Reducing Violence Against Women? A Scoping Review Lauren SheppardMoosa AlsubhiMarj Moodie Review Article Open access 27 January 2024 Pages: 283 - 296
Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana Yizhi LiangYuqian LinBoshen Jiao Original Research Article 24 January 2024 Pages: 353 - 362
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective Karissa M. JohnstonIvana F. AudhyaKatherine L. Gooch Original Research Article Open access 23 January 2024 Pages: 343 - 352
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA Tran T. DoanDavid W. HuttonLisa A. Prosser Original Research Article 22 January 2024 Pages: 375 - 390
Are Web-Based Valuation Surveys for Preference-Based Measures as Reliable as Face-to-Face Surveys? TTO, DCE and DCE with Duration Takeru ShiroiwaTakashi Fukuda Original Research Article Open access 13 January 2024 Pages: 391 - 400
Correction: Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance Jake T. W. WilliamsKaty J. L. BellMbathio Dieng Correction Open access 12 January 2024 Pages: 271 - 272
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries Néboa ZozayaJavier VillasecaÁlvaro Hidalgo-Vega Review Article 12 January 2024 Pages: 297 - 313
Cost-Effectiveness Analysis of Systemic Therapy for Intensification of Treatment in Metastatic Hormone-Sensitive Prostate Cancer in India Nidhi GuptaDharna GuptaShankar Prinja Original Research Article 10 January 2024 Pages: 415 - 426
Do Informal Care Recipients Internalise Carer Burden? Examining the Impact of Informal Care Receipt on Health Behaviours Jack ElliottIgor FranceticMatt Sutton Original Research Article Open access 10 January 2024 Pages: 209 - 225
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review Philipp WeberLeonie BirkholzJana Semrau Review Article Open access 08 January 2024 Pages: 165 - 179
Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses” Natalia KunstAnnisa SiuAnna Heath Letter to the Editor 23 December 2023 Pages: 265 - 267
An Optional Delinked Reward System: Making Pharmaceutical Innovation Work for Everyone Aidan Hollis Leading Article 22 December 2023 Pages: 155 - 164
Treatment Preferences of Adolescents and Young Adults with Depressive Symptoms: A Discrete Choice Experiment Ruth C. WaumansAnna D. T. MuntinghNeeltje M. Batelaan Original Research Article 18 December 2023 Pages: 401 - 413
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L Xin ZhangKarin M. VermeulenPaul F. M. Krabbe Correction Open access 16 December 2023 Pages: 269 - 269
Participatory Value Evaluation (PVE): A New Preference-Elicitation Method for Decision Making in Healthcare Sander BoxebeldNiek MouterJob van Exel Practical Application 16 December 2023 Pages: 145 - 154
Should Commercial Diagnostic Testing Be Stimulated or Discouraged? Analyzing Willingness-to-Pay and Market Externalities of Three Commercial Diagnostic Tests in The Netherlands Niek StadhoudersElla van VlietSuzanne Onstwedder Original Research Article Open access 15 December 2023 Pages: 193 - 207
Authors’ Reply to Gandjour: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?” Melanie BüssgenTom Stargardt Letter to the Editor Open access 02 December 2023 Pages: 127 - 128
Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?” Afschin Gandjour Letter to the Editor Open access 02 December 2023 Pages: 125 - 126
Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation Janet BouttellHeather FraserNeil Hawkins Original Research Article 28 November 2023 Pages: 243 - 254
Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review Akhil SasidharanBhavani Shankara BagepallyS Sajith Kumar Systematic Review 28 November 2023 Pages: 181 - 192
Health Service Utilisation of People Living with Psychosis: Validity of Self-report Compared with Administrative Data in a Randomised Controlled Trial Vergil DolarMary Lou ChattertonLidia Engel Original Research Article 21 November 2023 Pages: 255 - 264
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable? Jonathan KarnonAndrew PartingtonTimothy Schultz Current Opinion 18 November 2023 Pages: 273 - 281
Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022” Sieta T. de VriesNoral Huda S. Al-MugoterPeter G. M. Mol Research Letter 16 November 2023 Pages: 123 - 124
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older Shoroq M. AltawalbehAngela R. WateskaKenneth J. Smith Original Research Article 15 November 2023 Pages: 61 - 71
Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy Constanza VargasRebecca AddoStephen Goodall Original Research Article 11 November 2023 Pages: 73 - 84